Posture Detection for Automated Abdominal Binder

Status Completed

Clinical Trial Summary

The automated inflatable abdominal binder is an investigational device for the treatment of orthostatic hypotension (low blood pressure on standing) in autonomic failure patients. The purpose of this study is to evaluate the performance of the binder in detecting body posture during different types of human motion patterns and activities of daily living, and to develop new (and better) ways to detect upright posture. In particular, the investigators want to determine if activities of daily living, normally encountered by patients (lying down, sitting, standing, walking, and climbing up and down steps), interfere with the detection of upright posture used to trigger the device. Studies will be conducted in healthy subjects because the main purpose of this study is to evaluate posture detection rather than treating orthostatic hypotension.

Clinical Trial Description

The Primary Objective of this study is to develop and validate the algorithm needed to detect upright posture with a waist 3-axis accelerometer. A Secondary Objective is to determine the performance reliability of posture detection of the thigh and waist accelerometers when exposed to activities of daily living (standing, walking, climbing stairs). We will test the primary and secondary objectives in normal subjects using a single study design. Studies for both objectives will be conducted simultaneously on each subject on a single study day. Normal subjects will wear a device with the waist accelerometer incorporated within the controller box.

Subjects will be instrumented with the abdominal belt and controller box containing the waist accelerometer sensor. The external accelerometer sensor will be fixed with a Velcro around the thigh. In addition, subjects will wear two commercially available accelerometer sensors: 1) the ActivPal on the thigh of the other leg, and 2) an external accelerometer attached to the back of the belt at the level of the waist. The ActivPal can detect the upright posture but cannot distinguish between supine and sitting. The sensor placed on the back will be less affected by belly size in case of obese subjects. Both sensors will be used as a reference and for comparison. We will record all accelerometer signals during different body positions and activities. The activities will include lying down, sitting, getting up and standing still, walking, and climbing up and down steps for about one minute each for a total of 15-20 minutes per group of activities. Participants will perform 3 groups of activities. The order of activities within each group will be randomized. We might also ask you to perform ~3 small jumps to synchronize the sensors at the beginning, middle and the end of each set of activities. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02280369
Study type	Observational
Source	Vanderbilt University Medical Center
Contact
Status	Completed
Phase	N/A
Start date	September 2014
Completion date	January 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02705755` - TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)	Phase 2
Completed	`NCT00555880` - Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension	Phase 4
Terminated	`NCT00046163` - A Phase IV Study in Subjects With Neurogenic Orthostatic Hypotension	Phase 4
Withdrawn	`NCT03248271` - Effects of Insulin on Hypotension and Sarcopenia
Completed	`NCT00117585` - Orthostatic Hypotension in Rehabilitation Patients	N/A
Completed	`NCT03900000` - Improved Orthostatic Tolerance = Better Cognitive Function in Parkinson's Disease	N/A
Completed	`NCT03555799` - Evaluation of Changes of Venous Return After Spinal and Epidural Analgesia and Anesthesia by Ultrasound Guided Vena Cava Diameter Measurement
Terminated	`NCT02963181` - Effects of Melatonin to Reduce Nocturnal Hypertension in Patients With Neurogenic Orthostatic Hypotension	Early Phase 1
Completed	`NCT03602014` - Dose Response to the Norepinephrine Precursor Droxidopa in Hypotensive Individuals With Spinal Cord Injury	Phase 4
Completed	`NCT02700399` - Study of Pulse Pressure During Tilttable and Erigo® in Adult Patients With Acquired Brain Injury	N/A
Recruiting	`NCT01866787` - Study on Baroreceptor Function in Relation to Orthostatic Blood Pressure Regulation After Hip Surgery	N/A
Enrolling by invitation	`NCT04369131` - Controlling Orthostatic Hypotension in People With Cervical Spinal Cord Injury	N/A
Completed	`NCT00046475` - A Study for Patients With Neurogenic Orthostatic Hypotension	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.